semaglutide prediabetes progression to diabetes trial in Early Type 1 Semaglutide versus placebo in individuals

An unconventional mechanism of IL-1 secretion that requires type I IFN in lupus monocytes (Cold Spring Harbor Laboratory, 2023)

May your vials stay potent, your storage stay cold, and your protocols stay consistent.

Insulin use was reported for 34.6% of patients 180 days before the index date, and 62.1% had used either one or two medications in a GLD class other than GLP-1 RA, most often metformin (50.4%)

Kulshrestha, S., Tyagi, P., Sindhi, V., & Yadavilli, K

You can return to our office for weekly Lipo C injections initially, but we may recommend switching to monthly visits after the first few weeks

Learn more about trontinemab and other emerging Alzheimers therapeutics in late-stage clinical development